COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,031 Articles (22,627 medRxiv, 8,404 bioRxiv)

Most recent first Previous |  Page 1835: Articles 18341-18350  | Next

Trajectories of Hypoxemia & Respiratory System Mechanics of COVID-19 ARDS in the NorthCARDS dataset
Jafari, D., Gandomi-Sereshki, A., Makhnevich, A., Qiu, M., Rolston, D. M., Gottesman, E. P., Tsegaye, A., Mayo, P. H., Stewart, M. E., Zhang, M., Hajizadeh, N.
10.1101/2021.01.26.21250492 — Posted: 2021-01-28
Immune response to SARS-CoV-2 in the nasal mucosa in children and adults
Koch, C. M., Prigge, A. D., Anekalla, K. R., Shukla, A., Chi Do-Umehara, H., Setar, L., Chavez, J., Abdala-Valencia, H., Politanska, Y., Markov, N. S., Hahn, G. R., Heald-Sargent, T., Sanchez-Pinto, L. N., Muller, W. J., Misharin, A. V., Ridge, K. M., Coates, B. M.
10.1101/2021.01.26.21250269 — Posted: 2021-01-28
Individual factors underlie temperature variation in sickness and in health: influence of age, BMI and genetic factors in a multi-cohort study
Penfold, R. S., Zazzara, M. B., Österdahl, M. F., GSTT CovidCollaborative, , Welch, C., Ni Lochlainn, M., Freidin, M., Bowyer, R. C. E., Thompson, E. E. J., Antonelli, M., Tan, Y. X. R., Sudre, C., Modat, M., Murray, B., Wolf, J., Ourselin, S., Veenith, T., Lord, J. M., Steves, C. J.
10.1101/2021.01.26.21250480 — Posted: 2021-01-28
The angiotensin type 2 receptor agonist C21 restores respiratory function in COVID19 - a double-blind, randomized, placebo-controlled Phase 2 trial
Tornling, G., Batta, R., Porter, J., Bengtsson, T., Parmar, K., Kashiva, R., Cohrt, A. K., Westergaard, K., Hallberg, A., Dalsgaard, C.-J., Raud, J.
10.1101/2021.01.26.21250511 — Posted: 2021-01-28
Do examinations prepare students for higher education? A lesson from the Covid-19 lockdown.
Jones, H. L., Zini, V., Green, J. R., Prendergast, J. R., Scott, J.
10.1101/2021.01.26.428208 — Posted: 2021-01-27
SARS-CoV-2 emerging complexity
Bertacchini, F., Bilotta, E., Pantano, P. S.
10.1101/2021.01.27.428384 — Posted: 2021-01-27
Synthetic nanobody-SARS-CoV-2 receptor-binding domain structures identify distinct epitopes
Ahmad, J., Jiang, J., Boyd, L. F., Natarajan, K., Margulies, D. H.
10.1101/2021.01.27.428466 — Posted: 2021-01-27
Computational Analysis of Protein Stability and Allosteric Interaction Networks in Distinct Conformational Forms of the SARS-CoV-2 Spike D614G Mutant: Reconciling Functional Mechanisms through Allosteric Model of Spike Regulation
Verkhivker, G., Agajanian, S., Oztas, D., Gupta, G.
10.1101/2021.01.26.428331 — Posted: 2021-01-27
Lysosomal-Immune Axis Is Associated with COVID 19 Disease Severity: Insights from Patient Single Cell Data
Pande, R., Teeple, E., Huang, W., Klinger, K. W., Rajpal, D., Kumar, D.
10.1101/2021.01.27.428394 — Posted: 2021-01-27
E484K as an innovative phylogenetic event for viral evolution: Genomic analysis of the E484K spike mutation in SARS-CoV-2 lineages from Brazil
Ferrareze, P. A. G., Franceschi, V. B., Mayer, A. d. M., Caldana, G. D., Zimerman, R. A., Thompson, C. E.
10.1101/2021.01.27.426895 — Posted: 2021-01-27 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).